Lumosity

DEVICE4 trials

Sponsors

Lumos Labs, Inc., Rush University Medical Center, Beth Israel Deaconess Medical Center, University of Alabama at Birmingham

Conditions

Cognitive ImpairmentDeliriumHematologic NeoplasmsHematopoietic Cell TransplantMemory DeficitsMultiple Sclerosis (MS)Postoperative Cognitive DysfunctionRuptured Aneurysm

Unknown Phase

An Observational Pilot Study of Lumosity Computerized Cognitive Training in Subjects With Multiple Sclerosis

CompletedNCT02612935

Lumos Labs, Inc.Multiple Sclerosis (MS)

Start: 2015-03-31End: 2017-02-28Updated: 2017-05-25

Memory Training in Aneurysmal Subarachnoid Hemorrhage Patients

TerminatedNCT02864940

Rush University Medical CenterMemory Deficits, Ruptured Aneurysm, Subarachnoid Hemorrhage

Start: 2016-06-30End: 2018-08-28Updated: 2023-04-10

Prevention of Early Postoperative Decline

CompletedNCT02908464

Beth Israel Deaconess Medical CenterDelirium, Postoperative Cognitive Dysfunction

Start: 2016-11-30End: 2019-09-30Updated: 2020-06-16

Cognitive Training Intervention and Attitudes Towards Genetics

RecruitingNCT03094026

University of Alabama at BirminghamCognitive Impairment, Hematologic Neoplasms, Hematopoietic Cell Transplant

Start: 2017-08-21End: 2027-07-01Target: 60Updated: 2026-04-20

Related Papers

Adherence and satisfaction with remote cognitive training in blood or marrow transplant (BMT) survivors: The cognitive training and attitudes towards genetics (cTAG) study.

Journal of Clinical Oncology2023-06-01

Prevention of Early Postoperative Decline (PEaPoD): protocol for a randomized, controlled feasibility trial.

2018-12-118 citations